Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mutagenesis: the power to do harm.

D Williams1

  • 1Clinical Engineering Department, Royal Liverpool University Hospital, UK. dfw.ce@liverpool.ac.uk

Medical Device Technology
|February 6, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ligand binding to the (1 --> 3)-beta-D-glucan receptor stimulates NFkappaB activation, but not apoptosis in U937 cells.

Biochemical and biophysical research communications·1998
Same author

Health care for the school-age child.

Annual review of nursing research·1998
Same author

Antiproliferative mechanism of action of cryptophycin-52: kinetic stabilization of microtubule dynamics by high-affinity binding to microtubule ends.

Proceedings of the National Academy of Sciences of the United States of America·1998
Same author

Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major.

Infection and immunity·1998
Same author

Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost.

Annals of internal medicine·1998
Same author

Mental disorder and violence. A special (high security) hospital study.

The British journal of psychiatry : the journal of mental science·1998
Same journal

Safer arterial access.

Medical device technology·2010
Same journal

Building better surfaces.

Medical device technology·2010
Same journal

PVC: a broader perspective.

Medical device technology·2010
Same journal

Joining and forming using torsional ultrasonic principles.

Medical device technology·2010
Same journal

US regulation of combination products.

Medical device technology·2010
Same journal

Assessing biological safety of metals associated with medical devices.

Medical device technology·2010
See all related articles

Assessing mutagenicity risks from biomaterials in medical devices is complex. This article clarifies the significance of mutagenicity testing and result interpretation for medical device safety.

Area of Science:

  • Biomaterials Science
  • Toxicology
  • Medical Device Regulation

Background:

  • Medical device testing includes evaluating mutagenicity.
  • The actual risk of mutagenicity from biomaterials remains unclear.
  • Interpreting mutagenicity test results for biomaterials presents challenges.

Purpose of the Study:

  • To discuss the significance of mutagenicity testing for medical devices.
  • To explore the uncertainties surrounding mutagenicity risks associated with biomaterials.
  • To provide insights into the interpretation of mutagenicity test outcomes.

Main Methods:

  • Literature review on mutagenicity testing protocols for medical devices.
  • Analysis of regulatory guidelines concerning biomaterial safety.

Related Experiment Videos

  • Discussion of case studies and expert opinions on mutagenicity risk assessment.
  • Main Results:

    • Mutagenicity testing is a critical component of medical device safety assessment.
    • Quantifying the precise mutagenicity risk from biomaterials requires further research.
    • Standardized interpretation frameworks for mutagenicity test results are needed.

    Conclusions:

    • Clarifying mutagenicity risks is essential for ensuring patient safety with medical devices.
    • Improved methodologies for risk assessment and result interpretation are necessary.
    • This article highlights key considerations for the medical device industry and regulatory bodies.